vs
Royalty Pharma plc（RPRX）与思佳讯（SWKS）财务数据对比。点击上方公司名可切换其他公司
思佳讯的季度营收约是Royalty Pharma plc的1.7倍（$1.0B vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 7.6%，领先26.8%），思佳讯同比增速更快（8.6% vs 4.8%），过去两年Royalty Pharma plc的营收复合增速更高（4.6% vs -0.5%）
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
思佳讯是总部位于美国加利福尼亚州尔湾的半导体企业，公司股票在纳斯达克全球精选市场挂牌交易，股票代码为SWKS，同时也是标普500指数的成分股之一，在全球射频半导体领域拥有较高市场地位。
RPRX vs SWKS — 直观对比
营收规模更大
SWKS
是对方的1.7倍
$622.0M
营收增速更快
SWKS
高出3.8%
4.8%
净利率更高
RPRX
高出26.8%
7.6%
两年增速更快
RPRX
近两年复合增速
-0.5%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $622.0M | $1.0B |
| 净利润 | $214.2M | $79.2M |
| 毛利率 | — | 41.3% |
| 营业利润率 | 62.4% | 10.0% |
| 净利率 | 34.4% | 7.6% |
| 营收同比 | 4.8% | 8.6% |
| 净利润同比 | 2.9% | 15.3% |
| 每股收益（稀释后） | $0.49 | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RPRXSWKS
| Q1 26 | — | $1.0B | ||
| Q4 25 | $622.0M | $1.1B | ||
| Q3 25 | $609.3M | — | ||
| Q2 25 | $578.7M | $965.0M | ||
| Q1 25 | $568.2M | $953.2M | ||
| Q4 24 | $593.6M | $1.1B | ||
| Q3 24 | $564.7M | $1.0B | ||
| Q2 24 | $537.3M | $905.5M |
净利润RPRXSWKS
| Q1 26 | — | $79.2M | ||
| Q4 25 | $214.2M | $141.4M | ||
| Q3 25 | $288.2M | — | ||
| Q2 25 | $30.2M | $105.0M | ||
| Q1 25 | $238.3M | $68.7M | ||
| Q4 24 | $208.2M | $162.0M | ||
| Q3 24 | $544.0M | $60.5M | ||
| Q2 24 | $102.0M | $120.9M |
毛利率RPRXSWKS
| Q1 26 | — | 41.3% | ||
| Q4 25 | — | 40.7% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 41.6% | ||
| Q1 25 | — | 41.1% | ||
| Q4 24 | — | 41.4% | ||
| Q3 24 | — | 41.9% | ||
| Q2 24 | — | 40.2% |
营业利润率RPRXSWKS
| Q1 26 | — | 10.0% | ||
| Q4 25 | 62.4% | 10.1% | ||
| Q3 25 | 70.1% | — | ||
| Q2 25 | 36.3% | 11.5% | ||
| Q1 25 | 94.0% | 10.2% | ||
| Q4 24 | 60.9% | 16.9% | ||
| Q3 24 | — | 5.8% | ||
| Q2 24 | 50.2% | 14.4% |
净利率RPRXSWKS
| Q1 26 | — | 7.6% | ||
| Q4 25 | 34.4% | 12.9% | ||
| Q3 25 | 47.3% | — | ||
| Q2 25 | 5.2% | 10.9% | ||
| Q1 25 | 41.9% | 7.2% | ||
| Q4 24 | 35.1% | 15.2% | ||
| Q3 24 | 96.3% | 5.9% | ||
| Q2 24 | 19.0% | 13.4% |
每股收益（稀释后）RPRXSWKS
| Q1 26 | — | $0.53 | ||
| Q4 25 | $0.49 | $0.95 | ||
| Q3 25 | $0.67 | — | ||
| Q2 25 | $0.07 | $0.70 | ||
| Q1 25 | $0.55 | $0.43 | ||
| Q4 24 | $0.46 | $1.00 | ||
| Q3 24 | $1.21 | $0.36 | ||
| Q2 24 | $0.23 | $0.75 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $618.7M | $1.6B |
| 总债务越低越好 | $9.0B | $496.6M |
| 股东权益账面价值 | $9.7B | $5.8B |
| 总资产 | $19.6B | $7.9B |
| 负债/权益比越低杠杆越低 | 0.92× | 0.09× |
8季度趋势，按日历期对齐
现金及短期投资RPRXSWKS
| Q1 26 | — | $1.6B | ||
| Q4 25 | $618.7M | $1.4B | ||
| Q3 25 | $938.9M | — | ||
| Q2 25 | $631.9M | $1.3B | ||
| Q1 25 | $1.1B | $1.5B | ||
| Q4 24 | $929.0M | $1.7B | ||
| Q3 24 | $950.1M | $1.6B | ||
| Q2 24 | $1.8B | $1.3B |
总债务RPRXSWKS
| Q1 26 | — | $496.6M | ||
| Q4 25 | $9.0B | $496.4M | ||
| Q3 25 | $8.9B | — | ||
| Q2 25 | $8.0B | $496.2M | ||
| Q1 25 | $7.6B | $995.1M | ||
| Q4 24 | $7.6B | $994.7M | ||
| Q3 24 | $7.6B | $994.3M | ||
| Q2 24 | $7.6B | $994.0M |
股东权益RPRXSWKS
| Q1 26 | — | $5.8B | ||
| Q4 25 | $9.7B | $5.8B | ||
| Q3 25 | $9.6B | — | ||
| Q2 25 | $9.5B | $5.7B | ||
| Q1 25 | $9.8B | $5.9B | ||
| Q4 24 | $10.3B | $6.4B | ||
| Q3 24 | $10.3B | $6.3B | ||
| Q2 24 | $9.8B | $6.3B |
总资产RPRXSWKS
| Q1 26 | — | $7.9B | ||
| Q4 25 | $19.6B | $7.9B | ||
| Q3 25 | $19.3B | — | ||
| Q2 25 | $18.3B | $7.7B | ||
| Q1 25 | $17.6B | $7.9B | ||
| Q4 24 | $18.2B | $8.3B | ||
| Q3 24 | $18.0B | $8.3B | ||
| Q2 24 | $17.7B | $8.2B |
负债/权益比RPRXSWKS
| Q1 26 | — | 0.09× | ||
| Q4 25 | 0.92× | 0.09× | ||
| Q3 25 | 0.93× | — | ||
| Q2 25 | 0.84× | 0.09× | ||
| Q1 25 | 0.78× | 0.17× | ||
| Q4 24 | 0.74× | 0.16× | ||
| Q3 24 | 0.74× | 0.16× | ||
| Q2 24 | 0.78× | 0.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $827.1M | $395.5M |
| 自由现金流经营现金流 - 资本支出 | — | $339.0M |
| 自由现金流率自由现金流/营收 | — | 32.7% |
| 资本支出强度资本支出/营收 | — | 5.5% |
| 现金转化率经营现金流/净利润 | 3.86× | 4.99× |
| 过去12个月自由现金流最近4个季度 | — | $1.1B |
8季度趋势，按日历期对齐
经营现金流RPRXSWKS
| Q1 26 | — | $395.5M | ||
| Q4 25 | $827.1M | $200.0M | ||
| Q3 25 | $702.6M | — | ||
| Q2 25 | $364.0M | $314.2M | ||
| Q1 25 | $596.1M | $409.4M | ||
| Q4 24 | $742.5M | $377.2M | ||
| Q3 24 | $703.6M | $476.1M | ||
| Q2 24 | $658.2M | $273.4M |
自由现金流RPRXSWKS
| Q1 26 | — | $339.0M | ||
| Q4 25 | — | $144.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $252.7M | ||
| Q1 25 | — | $370.9M | ||
| Q4 24 | — | $338.2M | ||
| Q3 24 | — | $393.3M | ||
| Q2 24 | — | $249.0M |
自由现金流率RPRXSWKS
| Q1 26 | — | 32.7% | ||
| Q4 25 | — | 13.1% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 26.2% | ||
| Q1 25 | — | 38.9% | ||
| Q4 24 | — | 31.7% | ||
| Q3 24 | — | 38.4% | ||
| Q2 24 | — | 27.5% |
资本支出强度RPRXSWKS
| Q1 26 | — | 5.5% | ||
| Q4 25 | — | 5.1% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 6.4% | ||
| Q1 25 | — | 4.0% | ||
| Q4 24 | — | 3.6% | ||
| Q3 24 | — | 8.1% | ||
| Q2 24 | — | 2.7% |
现金转化率RPRXSWKS
| Q1 26 | — | 4.99× | ||
| Q4 25 | 3.86× | 1.41× | ||
| Q3 25 | 2.44× | — | ||
| Q2 25 | 12.06× | 2.99× | ||
| Q1 25 | 2.50× | 5.96× | ||
| Q4 24 | 3.57× | 2.33× | ||
| Q3 24 | 1.29× | 7.87× | ||
| Q2 24 | 6.45× | 2.26× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
SWKS
| Sales Channel Through Intermediary | $915.6M | 88% |
| Sales Channel Directly To Consumer | $119.8M | 12% |
